| Class 3 Device Recall BD FMC7 FITC | |
Date Initiated by Firm | January 25, 2016 |
Create Date | February 23, 2016 |
Recall Status1 |
Terminated 3 on October 18, 2016 |
Recall Number | Z-0851-2016 |
Recall Event ID |
73155 |
Product Classification |
Reagents,specific,analyte - Product Code MVU
|
Product | BD FMC7 FITC: Model 430918.
FMC7 is intended for in vitro diagnostic use in the identification of cells expressing FMC7 antigen.
Product Usage:
Analyte Specific Reagent. FMC7 is intended for in vitro diagnostic use in the identification of cells expressing FMC7 antigen. |
Code Information |
Model number: 340918: Lot number: 5341918. Incorrect expiry date on label 03/31/2017. correct expiry should be 6/30/16. |
Recalling Firm/ Manufacturer |
Becton, Dickinson and Company, BD Biosciences 2350 Qume Dr San Jose CA 95131-1812
|
For Additional Information Contact | Melissa J. Quinn 408-954-6080 |
Manufacturer Reason for Recall | Becton,
Dickinson and Company (BD) has determined that the FMC7 FITC (ASR) has an incorrect expiration date listed
on the vial label. |
FDA Determined Cause 2 | Under Investigation by firm |
Action | BD Biosciences sent an Urgent Medical Device Recall letters dated January 2016 via certified mail to affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed that the remaining stock of the product can be used until 6-30-16. however, if prefer they can discard all remaining stock of the affected lot and BD will replace.
The letter request customers complete the Tracking/verification form and returned to BD Biosciences, per the instructions (mail, fax, or email).
For questions contact your local BD representative or BD Customer Support at 877-232-8995 (prompt 3,3). |
Quantity in Commerce | 78 |
Distribution | Worldwide Distribution - US Nationwide in the staates of TX, NY, GA, NJ, AL, MA, IL, PA, DC, FL, CA, MD, OK. and coutry of Taiwan. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|